The role of SHANK2 and TGM2 in PBC should be confirmed using in vitro or animal models, and clinical validation in larger patient cohorts is necessary to assess their potential as biomarkers for diagnosis or prognosis. This evidence concerns the gene SHANK2 and primary biliary cholangitis.